[EN] SOLID ORAL DOSAGE FORMS OF 2R,6R-HYDROXYNORKETAMINE OR DERIVATIVES THEREOF<br/>[FR] FORMES POSOLOGIQUES SOLIDES ORALES DE 2R, 6R-HYDROXYNORKÉTAMINE OU LEURS DÉRIVÉS
申请人:SMALL PHARMA LTD
公开号:WO2017208031A1
公开(公告)日:2017-12-07
This invention relates to solid oral dosage forms of 2R,6R-hydroxynorketamine or prodrugs thereof having Formula Ib, including any pharmaceutically acceptable salt of the foregoing, for use in a therapeutic method for the treatment of a depressive disorder in a patient.
这项发明涉及具有公式Ib的2R,6R-羟基诺可胺或其前药的固体口服剂型,包括上述任何药用可接受盐,用于治疗患者的抑郁症的治疗方法。